 |
인쇄하기
취소
|
Safety profile of sibutramine to be independently determined in March, KFDA says
In view of latest studies suggesting higher risk of heart diseases, the Korea’s health watchdog will independently assess the safety profile of sibutramine next month, apart from the decisions in foreign countries.
The Korea Food and Drug Administration said it has already request Abbott Laboratories to separately submit the safety data of sibutramine for its review.
Meanwhile, Abbott sai...
The Korea Food and Drug Administration said it has already request Abbott Laboratories to separately submit the safety data of sibutramine for its review.
Meanwhile, Abbott sai...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.